Items where Author is " Wykoff Charles C."

Wong Tien Y. and Haskova Zdenka and Asik Kemal and Baumal Caroline R. and Csaky Karl G. and Eter Nicole and Ives Jane A. and Jaffe Glenn J. and Korobelnik Jean-François and Lin Hugh and Murata Toshinori and Ruamviboonsuk Paisan and Schlottmann Patricio G. and Seres András I. and Silverman David and Sun Xiaodong and Tang Yannan and Wells John A. and Hee Yoon Young and Wykoff Charles C. and Kollaborációs szervezet: YOSEMITE and RHINE Investigators and UNSPECIFIED and Papp András and Tóth-Molnár Edit: Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
OPHTHALMOLOGY, 131 (6). pp. 708-723. ISSN 0161-6420 (2024)

Jackson Timothy L. and Slakter Jason and Buyse Marc and Wang Kun and Dugel Pravin U. and Wykoff Charles C. and Boyer David S. and Gerometta Michael and Baldwin Megan E. and Price Clare F. and Kollaborációs szervezet: Opthea Study Group Investigator and Facskó Andrea and Kerényi Ágnes and Papp András and Vogt Gábor and et al.: A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration.
OPHTHALMOLOGY, 130 (6). pp. 588-597. ISSN 0161-6420 (2023)

Wykoff Charles C. and Abreu Francis and Adamis Anthony P. and Basu Karen and Eichenbaum David A. and Haskova Zdenka and Lin Hugh and Loewenstein Anat and Mohan Shaun and Pearce Ian A. and Sakamoto Taiji and Schlottmann Patricio G. and Papp András and Tóth-Molnár Edit and Kollaborációs szervezet: YOSEMITE and RHINE Investigators: Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
LANCET, 399 (10326). pp. 741-755. ISSN 0140-6736 (2022)